Headlands Technologies’s Cidara Therapeutics CDTX Stock Holding History

Headlands Technologies’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,595	Closed	-$6.32M	–	758
2025 Q4	$6.32M	Buy	+28,595	New	+$4.62M	0.53%	31

Headlands Technologies's CDTX Position: Q1 2026 in Review

Headlands Technologies sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 28,595 shares — an estimated $6.32M sold.

Headlands Technologies first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $6.32M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Headlands Technologies reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Headlands Technologies sold 28,595 Cidara Therapeutics shares in Q1 2026, an estimated $6.32M.
Headlands Technologies first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Headlands Technologies's Cidara Therapeutics position peaked at $6.32M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.